ADHD
253 results
1 - 100
ADHD - ADHD drug therapy - Image
EEG inaccurate in diagnosing ADHD- Parent training interventions for ADHD
Meditation therapies for attention‐deficit/hyperactivity disorder (ADHD)- St. John's wort not effective for treatment of ADHD
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in adults
- Bupropion for attention deficit hyperactivity disorder (ADHD) in adults
- Social skills training for ADHD in children
- 2019 guidelines for ADHD: structure plus medication
- In-school neurofeedback improves ADHD symptom scores
- Guanfacine effective for ADHD but side effects are significant
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Screening tool for adult ADHD of uncertain effectiveness
- Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)
- Extended‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- Immediate‐release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults
- A restriction diet will benefit some children with ADHD
- ADHD medications not associated with increased risk of CVD
- Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
- ADHD: A lot of research, not a lot of guidance
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Sleep counseling improves sleep and symptoms in children with ADHD
- Digital media use associated with ADHD symptom development among adolescents
- Cognitive‐behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adults
- Polyunsaturated fatty acids (PUFA) for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- Acupuncture for Attention Deficit Hyperactivity Disorder (ADHD) in children and adolescents: Cochrane systematic review
- Tricyclic antidepressants for attention deficit hyperactivity disorder (ADHD) in children and adolescents: Cochrane systematic review
- Higher risk of psychosis with amphetamines than methylphenidate in treatment of ADHD
- Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults: Cochrane systematic review
- Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years
- ADHD drugs do not increase serious CV events in children and young adults
- Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents
- No increased risk of ASD, ADHD, or SGA with first-trimester antidepressant use
- Acetaminophen use during pregnancy is not associated with risk of autism, ADHD, or intellectual disability
- Parent training interventions for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years: Cochrane systematic review
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non-randomised studies: Cochrane systematic review
- Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in non‐randomised studies